The Role of c‐Jun N‐Terminal Kinase (JNK) in Parkinson's Disease
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Given the critical role that the c‐Jun N‐terminal kinase (JNK) pathway plays in regulating many of the cellular processes which are affected in Parkinson's disease (PD), the possible importance of JNK in disease pathogenesis is being increasingly recognized. Here we review recent findings implicating the JNK signaling pathway in animal models of Parkinson's disease and discuss the relationship between this pathway and the prominent pathological processes observed in the disease state. We suggest that regulation of the JNK signaling pathway may be a central facet in potential treatments for the disease. IUBMB Life, 55: 267‐271, 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237 · cited 1×
“Overexpression of JIP causes the cytoplasmic retention of the JNK and thereby inhibits gene expression mediated by the JNK signaling pathway ( 13 ).”
BackgroundA Mammalian Scaffold Complex That Selectively Mediates MAP Kinase Activation
Whitmarsh, A. J., Cavanagh, J., Tournier, C., Yasuda, J., & Davis, R. J. (1998) · Science · doi:10.1126/science.281.5383.1671 · Cited by 652
A Portrait of Alzheimer Secretases--New Features and Familiar Faces
Esler, W. P., & Wolfe, M. S. (2001) · Science · doi:10.1126/science.1064638 · Cited by 493 · cited 1×
“The 42 amino acid amyloid b -peptide (A b ) comprises the principal proteinaceous component of amyloid plaques in the brains of patients with Alzheimer’s disease ( 17 ).”
BackgroundMeyer, D., Liu, A., & Margolis, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35113 · Cited by 126 · cited 1×
“JIP-1 contains a phosphotyrosine binding (PTB) domain in its C terminus ( 14 ) and a JNK binding domain (JBD) at the N terminus ( 15 ).”
Background
Cited by
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Lotharius, J., Falsig, J., van Beek, J., Payne, S., Dringen, R., Brundin, P., & Leist, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1746-05.2005 · Cited by 262
Castro-Caldas, M., Carvalho, A. N., Rodrigues, E., Henderson, C. J., Wolf, C. R., Rodrigues, C. M. P., & Gama, M. J. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8295-4 · Cited by 156
“Indeed, increased levels of phosphorylated JNK and its downstream target c-Jun were found in brains from PD patients [10, 11], and JNK is active in degenerating dopaminergic neurons in the substantia nigra pars compacta (SNpc) of MPTP-treated mice [11–14].”
BackgroundPeripheral expression of MAPK pathways in Alzheimer’s and Parkinson’s diseases
Wang, S., Zhang, C., Sheng, X., Zhang, X., Wang, B., & Zhang, G. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.08.017 · Cited by 72
Metadata
- Authors
- Peng, J., & Andersen, J.
- Venue
- IUBMB Life
- Publisher
- Wiley
- Published
- 2003-04
- Volume
- 55
- Issue
- 4-5
- Pages
- 267-271
- ISSN
- 1521-6543 (ISSN-L)
- 1521-6551
- OpenAlex
- W2086330310
- Cited by
- 91
- References
- 5
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of c‐Jun N‐Terminal Kinase (JNK) in Parkinson's Disease. https://app.cochat.ai/papers/10.1080/1521654031000121666
- The paper
- Peng, J., & Andersen, J. (2003). The Role of c‐Jun N‐Terminal Kinase (JNK) in Parkinson's Disease. IUBMB Life. https://doi.org/10.1080/1521654031000121666
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.